BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Zoledronic acid (Reclast) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Zoledronic acid (Reclast)\, from Clinical
 Trials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05677152-11024@assetmemo.bio
DTSTAMP:20261121T005449Z
DTSTART;VALUE=DATE:20301231
DTEND;VALUE=DATE:20310101
SUMMARY:Zoledronic acid (Reclast): Phase 2 readout est. (NCT05677152)
DESCRIPTION:Zoledronic acid (Reclast)\, phase 2.\nStudy: Influence of an An
 ti-osteoporotic Drug on Healing After Surgical Repair of Chronic Rotator C
 uff Lesions of the Shoulder\nEstimated primary completion: December 2030. 
 This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and
  it can move.\nDrug page: https://assetmemo.bio/drug/zoledronic-acid-recla
 st#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0
 5677152
URL:https://assetmemo.bio/drug/zoledronic-acid-reclast#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
